Received Sep 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
negatively impacted their thyroid gland; Long Covid; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN). The following information was reported: THYROID DISORDER (non-serious), outcome "unknown", described as "negatively impacted their thyroid gland"; POST-ACUTE COVID-19 SYNDROME (non-serious), outcome "unknown", described as "Long Covid". Additional information: Caller stated that they had been "inoculated" twice with the COVID vaccine and on the 2nd time they began to experience "Long Covid" which negatively impacted their thyroid gland. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.